This common vitamin could help fight one of the deadliest brain cancers

High-dose vitamin B3 is showing intriguing early promise as an addition to standard glioblastoma treatment, with 82% of patients in a small trial remaining progression-free after six months.

Researchers believe niacin may help revive immune cells suppressed by the cancer, but larger studies are still needed to confirm the benefit and safety.

In Gesundheit rückt FlexChar diese Geschichte in den Mittelpunkt: High-dose vitamin B3 is showing intriguing early promise as an addition to standard glioblastoma treatment, with 82% of patients in a small trial remaining progression-free after six months. FlexChar zeigt sie, weil sie gerade Suche und Gespräch treibt.